Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Squamous Cell Carcinoma of the Head or Neck”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT04857164
What this trial is testing

Study of Pembrolizumab Combined with Chemotherapy in the First Line Therapy for R/M HNSCC in China

Who this might be right for
Head and Neck Squamous Cell Carcinoma
Yuankai Shi 150
Early research (Phase 1)Looking for participantsNCT05983432
What this trial is testing

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

Who this might be right for
Non Small Cell Lung CancerEsophageal CancerSmall Cell Lung Cancer+7 more
SystImmune Inc. 540
Testing effectiveness (Phase 2)Looking for participantsNCT07254585
What this trial is testing

SYS6010 Combined With Enlonstobart In Recurrent Or Metastatic Head And Neck Squamous Cell Carcinoma

Who this might be right for
Head and Neck Squamous Cell Carcinoma
CSPC Megalith Biopharmaceutical Co.,Ltd. 70
Testing effectiveness (Phase 2)Study completedNCT00425750
What this trial is testing

Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Vanderbilt-Ingram Cancer Center 25
Testing effectiveness (Phase 2)Ended earlyNCT00093652
What this trial is testing

Oxaliplatin, Gefitinib, and Radiation Therapy in Treating Patients With Locally Advanced or Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Roswell Park Cancer Institute
Early research (Phase 1)Ended earlyNCT02628535
What this trial is testing

Safety Study of MGD009 in B7-H3-expressing Tumors

Who this might be right for
MesotheliomaBladder CancerMelanoma+10 more
MacroGenics 67
Testing effectiveness (Phase 2)Study completedNCT00024089
What this trial is testing

Gefitinib in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
National Cancer Institute (NCI) 60
Early research (Phase 1)Study completedNCT01772004
What this trial is testing

Avelumab in Metastatic or Locally Advanced Solid Tumors (JAVELIN Solid Tumor)

Who this might be right for
Solid Tumors
EMD Serono Research & Development Institute, Inc. 1,756
Testing effectiveness (Phase 2)Ended earlyNCT02449681
What this trial is testing

Study for Treatment of Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck or Skin

Who this might be right for
Metastatic Head-and-neck Squamous-cell Carcinoma
Rain Oncology Inc 30
Testing effectiveness (Phase 2)Study completedNCT00756444
What this trial is testing

Phase 2 Pharmacokinetic Trial of Chemotherapy With or Without Panitumumab in Patients With Metastatic and/or Recurrent Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell Carcinoma of Head and Neck
Amgen 67
Testing effectiveness (Phase 2)Study completedNCT01178944
What this trial is testing

Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer

Who this might be right for
Adenocarcinoma of the Gastroesophageal JunctionEsophageal Undifferentiated CarcinomaGastric Adenocarcinoma+14 more
Roswell Park Cancer Institute 35
Testing effectiveness (Phase 2)Looking for participantsNCT06682793
What this trial is testing

Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression

Who this might be right for
Solid Tumor, AdultColorectal CancerNon-Small Cell Lung+14 more
A2 Biotherapeutics Inc. 240
Testing effectiveness (Phase 2)Study completedNCT00012363
What this trial is testing

S0101 Gemcitabine and Irinotecan in Treating Patients With Metastatic or Recurrent Cancer of the Esophagus

Who this might be right for
Esophageal CancerGastric Cancer
SWOG Cancer Research Network 61
Large-scale testing (Phase 3)Study completedNCT02347332
What this trial is testing

Phase III Study of Vinflunine Plus Methotrexate Versus Methotrexate Alone in Patients With Head and Neck Cancer

Who this might be right for
Recurrent or Metastatic Head and Neck Carcinoma
Pierre Fabre Medicament 459
Testing effectiveness (Phase 2)Ended earlyNCT01488318
What this trial is testing

Cetuximab and Dasatinib in Recurrent Squamous Cell Carcinoma

Who this might be right for
Squamous Cell Carcinoma Of The Head And Neck
Julie E. Bauman, MD, MPH 21
Testing effectiveness (Phase 2)Study completedNCT03083873
What this trial is testing

Study of LN-145/LN-145-S1 Autologous Tumor Infiltrating Lymphocytes in the Treatment of Squamous Cell Carcinoma of the Head & Neck

Who this might be right for
Squamous Cell Carcinoma of the Head and Neck
Iovance Biotherapeutics, Inc. 64
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07688291
What this trial is testing

A Phase II Study of PD-1/IL-2α-bias Bispecific Antibody Fusion Protein Monotherapy in Advanced Esophageal Squamous Cell Carcinoma After Failure of Prior ICI Plus Platinum-Based Chemotherapy

Who this might be right for
Esophageal Squamous Carcinoma Cell
Beijing GoBroad Hospital 40
Testing effectiveness (Phase 2)Study completedNCT00114283
What this trial is testing

Lapatinib Ditosylate in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Recurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the HypopharynxRecurrent Squamous Cell Carcinoma of the Larynx+31 more
National Cancer Institute (NCI) 30
Testing effectiveness (Phase 2)UnknownNCT03771820
What this trial is testing

Combination Therapy With NC-6004 and Pembrolizumab in Head and Neck Cancer Subjects Who Have Failed Platinum Regimen

Who this might be right for
SCCHN
NanoCarrier Co., Ltd. 136
Testing effectiveness (Phase 2)Study completedNCT00003443
What this trial is testing

Bryostatin 1 in Treating Patients With Metastatic or Recurrent Head and Neck Cancer

Who this might be right for
Head and Neck Cancer
Memorial Sloan Kettering Cancer Center
Next Page